Nu Skin Enterprises, Inc. (NUS)
NYSEConsumer StaplesHousehold & Personal ProductsSnapshot 2026-09-04
$4.84+2.98%
Close 2026-09-04 · 1-day change
NYSEConsumer StaplesHousehold & Personal ProductsSnapshot 2026-09-04
QuarterlyIQ Insights · NUS
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||||||
| Revenues | 1,375.3 | 1,485.2 | 1,732.1 | 1,969.1 | 2,225.7 | 2,695.7 | 2,581.9 | 2,420.4 | 2,679.0 | 2,279.1 | 2,207.8 | — | — | 3,176.7 | 2,132.3 | 1,719.6 | — |
| Total Revenues | — | — | — | — | — | — | — | — | — | 2,279.1 | 2,207.8 | — | — | 3,176.7 | 2,132.3 | 1,719.6 | — |
| Cost of Revenues | 423.8 | 453.8 | 550.2 | 611.9 | 630.9 | 675.2 | 658.0 | 581.4 | 634.1 | — | — | — | — | — | — | — | — |
| Gross Profit | 951.5 | 1,031.4 | 1,181.9 | 1,357.3 | 1,594.7 | 2,020.4 | 1,923.9 | 1,839.0 | 2,044.9 | 1,777.0 | 1,707.3 | 1,757.5 | 2,091.1 | 2,670.9 | 1,779.1 | 1,397.0 | 1,264.8 |
| Operating Expenses & Income | |||||||||||||||||
| R&D Expenses | — | 10.8 | 13.0 | 22.6 | 23.3 | 27.2 | 23.3 | 30.1 | 23.0 | 22.0 | 24.3 | 20.1 | 18.9 | 18.0 | 14.9 | 13.6 | — |
| Operating Income | (10.4) | 65.8 | (151.6) | 48.3 | 110.8 | 234.0 | 257.6 | 267.4 | 240.9 | 274.5 | 231.1 | 244.7 | 352.2 | 554.1 | 340.8 | 233.7 | 217.1 |
| Earnings from Continuing Operations | |||||||||||||||||
| Interest Expense | — | 13.9 | 26.4 | 25.6 | 13.5 | 11.0 | 13.1 | 19.2 | 21.8 | 22.2 | 15.6 | 7.9 | 5.7 | 3.0 | 5.2 | 4.8 | — |
| Other Non-Operating Income / Expenses | (0.3) | (31.8) | 2.9 | 3.9 | (8.4) | (1.5) | (1.3) | (12.3) | (21.2) | (8.9) | (18.3) | (32.7) | (53.7) | 2.8 | 4.4 | (7.0) | (9.4) |
| Asset Writedown | — | 25.1 | 181.1 | 0.0 | 9.9 | 31.9 | 0.0 | — | — | — | — | — | — | — | — | — | — |
| EBT, Incl. Unusual Items | (26.4) | 196.2 | (175.1) | 26.6 | 89.0 | 232.5 | 256.2 | 255.2 | 219.7 | 265.6 | 212.8 | 212.0 | 298.5 | 556.9 | 345.2 | 226.8 | 207.6 |
| Income Tax Expense | 190.0 | 36.0 | (28.5) | 18.0 | (15.8) | 85.2 | 64.9 | 81.6 | 97.8 | 136.1 | 69.8 | 78.9 | 109.3 | 192.1 | 123.6 | 73.4 | 71.6 |
| Net Income | |||||||||||||||||
| Net Income | (216.4) | 160.2 | (146.6) | 8.6 | 104.8 | 147.3 | 191.4 | 173.6 | 121.9 | 129.4 | 143.1 | 133.0 | 189.2 | 364.9 | 221.6 | 153.3 | 136.1 |
| Per Share | |||||||||||||||||
| Basic EPS | (4.45) | 3.25 | (2.95) | 0.17 | 2.10 | 2.93 | 3.66 | 3.13 | 2.21 | 2.45 | 2.58 | 2.29 | 3.20 | 6.23 | 3.66 | 2.47 | 2.18 |
| Diluted EPS | (4.45) | 3.18 | (2.95) | 0.17 | 2.07 | 2.86 | 3.63 | 3.10 | 2.16 | 2.36 | 2.55 | 2.25 | 3.11 | 5.94 | 3.52 | 2.38 | 2.11 |
| Revenue per Share | 28.30 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividend per Share | — | — | — | — | — | — | — | — | — | — | — | — | 0.35 | 0.30 | 0.20 | 0.16 | — |
| Basic Weighted Avg Shares | 48.6 | 49.3 | 49.7 | 49.7 | 50.0 | 50.2 | 52.3 | 55.5 | 55.2 | 52.8 | 55.4 | 58.0 | 59.1 | 58.6 | 60.6 | 62.1 | 62.4 |
| Diluted Weighted Avg Shares | 48.6 | 50.3 | 49.7 | 49.9 | 50.5 | 51.4 | 52.8 | 55.9 | 56.5 | 54.9 | 56.1 | 59.1 | 60.9 | 61.4 | 63.0 | 64.5 | 64.5 |
| Supplemental | |||||||||||||||||
| EBITDA | — | 118.0 | (81.8) | 119.2 | 183.4 | 310.3 | 331.6 | 344.1 | 323.9 | 346.0 | 303.5 | 316.1 | 407.1 | 589.0 | 374.3 | 266.6 | 246.7 |
| EBIT | (10.4) | 65.8 | (151.6) | 48.3 | 110.8 | 234.0 | 257.6 | 267.4 | 240.9 | 274.5 | 231.1 | 244.7 | 352.2 | 554.1 | 340.8 | 233.7 | 217.1 |
| Effective Tax Rate | -719.9% | — | — | 67.7% | -17.8% | 36.6% | 25.3% | 32.0% | 44.5% | 51.3% | 32.8% | 37.2% | 36.6% | 34.5% | 35.8% | 32.4% | 34.5% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.